Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
41.2M
-
Shares change
-
+441K
-
Total reported value, excl. options
-
$920M
-
Value change
-
+$12M
-
Number of buys
-
57
-
Number of sells
-
-27
-
Price
-
$22.30
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2020
99 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q2 2020.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.2M shares
of 66.4M outstanding shares and own 62.1% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5.21M shares), NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (4.41M shares), PRIMECAP MANAGEMENT CO/CA/ (3.54M shares), BlackRock Inc. (2.8M shares), BAKER BROS. ADVISORS LP (2.7M shares), WELLINGTON MANAGEMENT GROUP LLP (2.6M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.47M shares), FEDERATED HERMES, INC. (2.27M shares), and VANGUARD GROUP INC (1.97M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.